Dr. Aristotle Voineskos is Professor of Psychiatry at the University of Toronto, Chief of the Schizophrenia Division and Director of the Slaight Family Centre for Youth in Transition at the Centre for Addiction and Mental Health (CAMH), in Toronto, Canada. This is Canada’s first centre dedicated to understanding and treating severe mental illness and addictions for youth from the late teens through early adulthood. The main goal of the Slaight Family Centre is to put more young people experiencing severe mental illness on a path to recovery through improved combinations of existing treatments, and through clinical research and education that studies new treatments, improves early identification and access to care, and streamlines service delivery.
Dr. Voineskos also runs his own research program as Head of the Kimel Family Translational Imaging-Genetics Laboratory at CAMH. Dr. Voineskos’s work includes using structural and functional neuroimaging in medication-based, brain stimulation, and behavioural treatment studies in schizophrenia and related disorders. This approach identifies the effects of existing and new treatments on brain structure and function, and aims to use neuroimaging to predict treatment response. He is currently leading several multi-site neuroimaging studies in North America, and holds operating funding as Principal Investigator from the National Institute of Mental Health in the U.S., the Canadian Institutes of Health Research, the Canada Foundation for Innovation, the Ontario Ministry of Research and Innovation, and from the Brain and Behavior Research Foundation as a NARSAD Independent Investigator.